A GLOBAL LEADER IN AESTHETIC AND CORRECTIVE TREATMENTS
Q-Med, a Galderma division, develops, manufactures and markets solutions for aesthetic and corrective treatments.
The division offers a complete worldwide portfolio in the aesthetic field including the brands Restylane, Emervel. Deflux, Solesta and Durolane are other products improving patients’ health in the corrective field.
Since 2011, Q-Med is wholly owned by Galderma, a pharmaceutical company with nearly 4 000 employees specialized in dermatology and present in more than 70 countries. The site in Uppsala, Sweden, is Galderma’s Global Center of Excellence for aesthetic and Corrective solutions with state-of-the-art research, development and manufacturing.
For more information about Galderma, please visit www.galderma.com